U.S. Intravenous Solutions Market (2026 - 2033) Size, Share & Trends Analysis Report By Type (Total Parenteral Nutrition (TPN), Peripheral Parenteral Nutrition (PPN)), By Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Type
                        1.2.2. Nutrient
                        1.2.3. End use
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Aging Population and Higher Hospitalization Rates
                            3.2.1.2. Increasing Surgical Procedures and Critical Care Admissions
                            3.2.1.3. Rising Prevalence of Chronic Diseases
                            3.2.1.4. Growth of Home Infusion and Outpatient Care
                            3.2.1.5. Increasing adoption of immuno-nutrition formulas
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Shortage of Parenteral Nutrition Products
                            3.2.2.2. High Risk of Infections
                        3.2.3. Industry Opportunity Analysis
                        3.2.4. Industry Challenge Analysis
                        3.2.5. Regulatory Framework
                            3.2.5.1. Standards and Compliances
                                3.2.5.1.1. North America
                                3.2.5.1.2. Europe
                                3.2.5.1.3. Asia Pacific
                                3.2.5.1.4. Latin America
                                3.2.5.1.5. MEA
                    3.3. Business Environment Analysis
                        3.3.1. Porter’s Five Forces Analysis
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTLE Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Economic and Social landscape
                            3.3.2.3. Technological landscape
                            3.3.2.4. Environmental landscape
                            3.3.2.5. Legal Landscape
Chapter 4. Intravenous Solutions Market: Product Estimates & Trend Analysis
                    4.1. Product Segment Dashboard
                    4.2. Product Market Share Movement Analysis, 2025 & 2033
                    4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (Volume, Thousand Units, Revenue USD Million)
                    4.4. Total Parenteral Nutrition
                        4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
                    4.5. Peripheral Parenteral Nutrition
                        4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Chapter 5. Intravenous Solutions Market: Nutrient Estimates & Trend Analysis
                    5.1. Nutrient Segment Dashboard
                    5.2. Nutrient Market Share Movement Analysis, 2025 & 2033
                    5.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (Volume, Thousand Units, Revenue USD Million)
                    5.4. Carbohydrates
                        5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
                    5.5. Vitamins & Minerals
                        5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
                    5.6. Single-dose Amino Acids
                        5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
                    5.7. Parenteral Lipid Emulsion
                        5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 Volume, Thousand Units, Revenue USD Million)
                    5.8. Others
                        5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Chapter 6. Intravenous Solutions Market: End Use Estimates & Trend Analysis
                    6.1. End Use Segment Dashboard
                    6.2. End Use Market Share Movement Analysis, 2025 & 2033
                    6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (Volume, Thousand Units, Revenue USD Million)
                    6.4. Home
                        6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
                    6.5. Hospitals
                        6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
                    6.6. Infusion Centers
                        6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Chapter 7. Competitive Landscape
                    7.1. Company Market Position Analysis, 2025
                    7.2. Company Market Share Analysis, 2025
                    7.3. Company Categorization
                    7.4. Company Profiles/Listing
                        7.4.1. Fresenius Kabi AG
                            7.4.1.1. Overview
                            7.4.1.2. Financial performance
                            7.4.1.3. Product benchmarking
                            7.4.1.4. Strategic initiatives
                        7.4.2. B. Braun SE
                            7.4.2.1. Overview
                            7.4.2.2. Financial performance
                            7.4.2.3. Product benchmarking
                            7.4.2.4. Strategic initiatives
                        7.4.3. Baxter
                            7.4.3.1. Overview
                            7.4.3.2. Financial performance
                            7.4.3.3. Product benchmarking
                            7.4.3.4. Strategic initiatives
                        7.4.4. Otsuka Pharmaceutical Co., Ltd.
                            7.4.4.1. Overview
                            7.4.4.2. Financial performance
                            7.4.4.3. Product benchmarking
                            7.4.4.4. Strategic initiatives
                        7.4.5. Pfizer, Inc.
                            7.4.5.1. Overview
                            7.4.5.2. Financial performance
                            7.4.5.3. Product benchmarking
                            7.4.5.4. Strategic initiatives
                        7.4.6. JW Life Science
                            7.4.6.1. Overview
                            7.4.6.2. Financial performance
                            7.4.6.3. Product benchmarking
                            7.4.6.4. Strategic initiatives
                        7.4.7. CSL Vifor (formerly Vifor Pharma)
                            7.4.7.1. Overview
                            7.4.7.2. Financial performance
                            7.4.7.3. Product benchmarking
                            7.4.7.4. Strategic initiatives
                        7.4.8. ICU Medical, Inc.
                            7.4.8.1. Overview
                            7.4.8.2. Financial performance
                            7.4.8.3. Product benchmarking
                            7.4.8.4. Strategic initiatives
                        7.4.9. Amphastar Pharmaceuticals, Inc.
                            7.4.9.1. Overview
                            7.4.9.2. Financial performance
                            7.4.9.3. Product benchmarking
                            7.4.9.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 List of secondary data sources
Table 3 U.S. Intravenous Solutions market, by type, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Table 4 U.S. Intravenous Solutions market, by nutrient, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Table 5 U.S. Intravenous Solutions market, by end use, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)

List of Figures

Fig. 1 Intravenous solutions market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape
Fig. 12 U.S. Intravenous solutions market dynamics
Fig. 13 U.S. Intravenous solutions market: PORTER’s analysis
Fig. 14 U.S Intravenous solutions market: PESTEL analysis
Fig. 15 U.S. Intravenous solutions market: by type: key takeaways
Fig. 16 U.S. Intravenous solutions market, by type: market share, 2025 & 2033
Fig. 17 Total parenteral nutrition market, 2021 - 2033 (Volume, Thousand Units, Revenue Volume, Thousand Units, Revenue USD Million)
Fig. 18 Peripheral parenteral nutrition market, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Fig. 19 Intravenous solutions market, by end-use: key takeaways
Fig. 20 Intravenous solutions market, by nutrients: market share, 2025 & 2033
Fig. 21 Carbohydrates market, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Fig. 22 Single-dose amino acid solution market, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Fig. 23 Vitamins and minerals, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Fig. 24 Parenteral lipid emulsion, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Fig. 25 Others market, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Fig. 26 Intravenous solutions market by end use: key takeaways
Fig. 27 Intravenous solutions market, by end use: market share, 2025 & 2033
Fig. 28 Home market, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Fig. 29 Hospitals market, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)
Fig. 30 Infusion Centers market, 2021 - 2033 (Volume, Thousand Units, Revenue USD Million)